Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Gamma Fraction

Immunology & Autoimmune

Gamma fracGamma globulin fractionGamma region (SPEP)SPEP gamma

Review status

Currently under review

Pending specialist review and validation.

What it shows

Gamma Fraction is part of a serum protein electrophoresis test that evaluates the gamma globulin portion of your blood proteins. Gamma globulins are mostly antibodies made by plasma cells that help your body recognize and fight infections.

By separating your blood proteins into groups, the test reveals the overall pattern of your immune proteins. This pattern helps your care team see whether your immune system is broadly activated or whether a single group of cells is making a distinct protein.

Why it matters

Clinicians use the gamma fraction to investigate persistent inflammation, recurrent infections, autoimmune conditions, chronic liver disease, and plasma cell disorders such as monoclonal gammopathy of undetermined significance and multiple myeloma. It can also be used to monitor known conditions and to assess response to therapy over time.

Changes in this fraction can point to a generalized immune response, loss of antibodies, or the presence of a monoclonal protein. Recognizing the pattern helps determine whether additional tests are needed and guides the urgency and type of follow-up.

Understanding your results

Your result is interpreted in the context of your symptoms, examination, and other laboratory findings. A higher gamma fraction often reflects recent or ongoing immune stimulation; certain patterns raise concern for a monoclonal protein and may prompt confirmatory tests such as immunofixation or serum free light chains. A lower gamma fraction can be seen with immune deficiency, protein loss through the kidneys or gut, or after specific therapies.

If your result is unexpected, your clinician may recommend repeating the test to confirm it, ordering targeted blood and urine studies, or obtaining imaging depending on your situation. Values can fluctuate, so trends over time are often more informative than a single measurement. Do not start or stop medicines or supplements without medical advice.

Reference ranges

6.215.2 g/L
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Gamma Fraction

  • Recent antibody treatments

    Intravenous immunoglobulin infusions and monoclonal antibody therapies can transiently raise the gamma fraction, sometimes mimicking a disease pattern on electrophoresis.

  • Infections and inflammation

    Acute or chronic infections and autoimmune activity can increase gamma globulins, usually in a broad pattern that reflects overall immune system activation.

  • Hydration and specimen quality

    Dehydration concentrates blood proteins and overhydration dilutes them. Hemolysis or marked lipemia can also distort electrophoresis patterns and complicate interpretation.

  • Protein loss and liver function

    Kidney or gastrointestinal protein loss and impaired antibody production from liver or bone marrow disorders can lower the gamma fraction.

  • Medications and immune suppression

    Corticosteroids, chemotherapy, and other immunosuppressive drugs may reduce antibody levels and lower the gamma fraction during treatment.

  • Age and pregnancy

    Antibody levels vary across the lifespan and can shift during pregnancy. Your clinician will interpret results with age and physiologic state in mind.

2026

References

  1. McGill University Health Centre. (2013, August 26). Gamma Fraction (Task CD 743402). Laboratory reference ranges.
  2. National Institute for Health and Care Excellence. (2016, last updated 2024). Myeloma: Diagnosis and management (NG35). External link
  3. Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M. V., Kumar, S., ... International Myeloma Working Group. (2014). International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. The Lancet Oncology, 15(12), e538–e548. External link
  4. Keren, D. F. (2012). Protein electrophoresis in clinical diagnosis (2nd ed.). American Society for Clinical Pathology Press.